Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrospective study of Guizhi Gancao Decoction and Jingjie Lianqiao Decoction for post-COVID-19 symptoms
jRCT1061240052Suspended
- Sponsor
- Linyu Biotech
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Open-label trial of guizhi gancao decoction and jingjie lianqiao decoction in post-COVID syndrome (2 arms), sponsored by Linyu Biotech. Primary endpoints: Changes in memory impairment, Changes in sleep disturbance and 1 more. Started Jun 2023; status: suspended.
02
Drugs
guizhi gancao decoctionjingjie lianqiao decoction
03
Conditions
post-COVID syndrome
Beyond the preview
Go deeper on jRCT1061240052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1061240052.